Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ADGRL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZNF93 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RREB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITPRIPL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
GPD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CRIPT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UTRN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARP9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEPP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MARCH9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TP53INP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLAC8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDK5R1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AP1G1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCM2L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2J1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RHEB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VAMP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on